Business
PAOG Initiates Second CBD Nutraceutical Production Run As Early Results Of First Run Indicate Sell Out
PAOG Initiates Second CBD Nutraceutical Production Run As Early Results Of First Run Indicate Sell Out.
About this update from Pao Group, Inc.
[{"type":"text","content":"\n\n\n\nPAOG Initiates Second CBD Nutraceutical Production Run As Early Results Of First Run Indicate Sell Out\n\n/* Style Definitions */\nspan.prnews_span\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\na.prnews_a\n{\ncolor:blue;\n}\nli.prnews_li\n{\nfont-size:8pt;\nfont-family:\"Arial\";\ncolor:black;\n}\np.prnews_p\n{\nfont-size:0.62em;\nfont-family:\"Arial\";\ncolor:black;\nmargin:0in;\n}\n\n\n\n\n\n\nPAOG Initiates Second CBD Nutraceutical Production Run As Early Results Of First Run Indicate Sell Out\nPR Newswire\nSANDUSKY, OH, Nov. 2, 2021\n\n\n\nSANDUSKY, OH, Nov. 2, 2021 /PRNewswire/ -- PAO Group, Inc. (USOTC: PAOG) today announced initiating a second production run of the first CBD nutraceuticals products the company recently introduced. \nPAOG recently announced the launch of its first two CBD nutraceutical products, RelaxRX CBD, a sleep aid, and RehabRX CBD, a salve.\nPAOG has confirmed shipping its first and second CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (USOTC: USMJ).  Even before the product has been set up for sale online at www.USMJ.com, inquires for the product have indicated a rapid sellout.\nLast year, the company acquired intellectual property form Nouveau Life Pharmaceuticals (NOUV) derived through research into CBD extracted in association with a patented extraction method (U.S. Patent No. 9,199,960).  PAOG is developing both pharmaceutical and nutraceutical treatments for humans based on this intellectual property. \nPAOG is on track to realize its first revenue this year, starting in Q4 2021, since acquiring the extraction technology.\nPAOG has confirmed shipping its first and second CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (USOTC: USMJ).  The product will soon be for sale online at www.USMJ.com. \nPAOG expects revenue to grow rapidly following its first and second CBD nutraceutical product launches as the company has follow on products lined up to follow these products adding to overall sales potential.\nLearn more about USMJ's ecommerce site at www.usmj.com.\nLearn more about PAOG at www.paogroupinc.com.\nForward-Looking Statements: Certain statements in this news release may contain forward-looking information within the meaning of Rule 175 under the Securiti...